Posts

Showing posts with the label cost_effectiveness

New publications in well being economics and genomics eighth June 2022

Image
You can view the original post here One publication from the previous week: Accounting for Intergenerational Cascade Testing in Financial Evaluations of Scientific Genomics: A Scoping Evaluation | li n k I’m glad to share every other publications from this week that I’ve missed – simply let me know. I publish these updates weekly, on a Tuesday, however provided that I’ve seen related publications. In case you don’t see an replace on a Tuesday, assume it has been a quiet week for publications in well being economics and genomics. Like this: Like Loading... Associated You can view the original post here Show Original: https://librareview.com/new-publications-in-well-being-economics-and-genomics-eighth-june-2022/

Journal round-up: PharmacoEconomics – Open 6(3)

Image
You can view the original post here Our authors present common round-ups of the most recent peer-reviewed journals. We cowl all problems with main well being economics journals in addition to different notable releases. Go to our journal round-up log to see previous editions organised by publication title. In case you’d like to write down a journal round-up, get in contact. This subject of PharmacoEconomics – Open is dominated by utilized financial evaluations. There are utilized research on oral glucose-lowering drugs for diabetes , machine implantation for glaucoma , a prompt-based intervention for the management of head and neck cancer , and movement therapy in neurorehabilitation . There’s additionally a scientific assessment of financial evaluations of community distribution of Naloxone . And, although not a cost-effectiveness mannequin per se, one other modelling examine demonstrates the doubtless big advantage of rapid initiation of ART for HIV in Spain. The f...